Save on this medicine
Other brands with the same active ingredient
These brands contain the same active ingredient (Ergometrine Maleate). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.
ইঙ্গিত ও ব্যবহার
Active management of the third stage of labour; treatment and prevention of postpartum haemorrhage; control of excessive uterine bleeding; and bleeding following childbirth or abortion.
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
Adults:
Intramuscular use in adults: For active management of the third stage of labour, give 0.5 mg together with 5 units of oxytocin after delivery of the infant's anterior shoulder, or immediately after delivery. For treatment and prevention of postpartum haemorrhage, give 0.2 mg, which may be repeated every 2 to 4 hours as needed in severe bleeding. Intravenous use in adults: For excessive uterine bleeding, give 0.2 mg by IV injection over at least 1 minute. This may be followed by oral doses of 0.2 to 0.4 mg 2 to 4 times daily until the risk of uterine atony or haemorrhage has passed (usually 48 hours). Oral use in adults: For postpartum and post-abortion bleeding, give 0.2 to 0.4 mg 2 to 4 times daily until the risk of uterine atony and haemorrhage has passed (usually 48 hours), for a maximum duration of 1 week postpartum.
পার্শ্বপ্রতিক্রিয়া
Nausea, vomiting, stomach pain, and diarrhoea may occur, along with headache, dizziness, and ringing in the ears. It can also cause chest pain, palpitations, a slowed heartbeat, temporary rise in blood pressure, and other irregular heart rhythms. Breathlessness, occasional skin rashes, and shock have also been reported.
সতর্কতা ও নিষেধাজ্ঞা
Warnings & Precautions
Breech and abnormal foetal presentation; hypertension; chronic anaemia; hepatic, renal, respiratory or cardiac impairment; toxemia; lactation; hypocalcaemia. Monitor BP, pulse and uterine response.
নিষেধাজ্ঞা
Contraindicated in pregnancy, during the 1st and 2nd stages of labour, and in patients with pre-eclampsia, eclampsia, threatened spontaneous abortion, or porphyria.